Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Free Cash Flow (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Free Cash Flow for 4 consecutive years, with $997.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 22.93% year-over-year to $997.0 million, compared with a TTM value of $1.8 billion through Dec 2025, up 17.31%, and an annual FY2025 reading of $1.8 billion, up 17.31% over the prior year.
  • Free Cash Flow was $997.0 million for Q4 2025 at GE HealthCare Technologies, up from $572.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $1.2 billion in Q4 2022 and bottomed at -$275.0 million in Q2 2024.
  • Average Free Cash Flow over 4 years is $443.1 million, with a median of $476.0 million recorded in 2022.
  • The sharpest move saw Free Cash Flow tumbled 176.92% in 2023, then soared 132.73% in 2025.
  • Year by year, Free Cash Flow stood at $1.2 billion in 2022, then decreased by 17.59% to $956.0 million in 2023, then dropped by 15.17% to $811.0 million in 2024, then rose by 22.93% to $997.0 million in 2025.
  • Business Quant data shows Free Cash Flow for GEHC at $997.0 million in Q4 2025, $572.0 million in Q3 2025, and $90.0 million in Q2 2025.